Home / Investors / Press releases

Press releases

Here you will find all press releases from XVIVO.

Showing 1 to 30 out of 32 posts.

21 Dec, 2021

XVIVO accelerates their business in Brazil by signing a partnership contract with Contatti Medical

8 Dec, 2021

In-line with XVIVO’s dedication to the US market, Fredrik Dalborg is appointed Managing Director North America

30 Nov, 2021

Increased number of shares and votes in XVIVO Perfusion AB (publ)

22 Nov, 2021

XVIVO expands its management team by appointing Jaya Tiwari to Vice President Clinical and Regulatory Affairs for the US

9 Nov, 2021

XVIVO completes the acquisition of Star Teams Inc.

28 Oct, 2021

XVIVO Perfusion has carried out a directed share issue of 746,269 shares at a subscription price of SEK 335 per share

28 Oct, 2021

XVIVO Perfusion intends to carry out a directed issue of shares

28 Oct, 2021

XVIVO has entered into an agreement to acquire the US organ recovery company Star Teams and finances the acquisition through a private placement of new shares

21 Oct, 2021

XVIVO presents interim report Januari-September 2021

18 Oct, 2021

Record for a donor heart outside the body using ground-breaking XVIVO technology

7 Oct, 2021

Conference call on Interim Report

5 Oct, 2021

Advance publication of interim report January-September 2021

30 Sep, 2021

Nomination committee of XVIVO Perfusion AB (publ)

23 Sep, 2021

Language correction: XVIVO Capital Markets Day presents strategic focus areas for 2022-2026

23 Sep, 2021

XVIVO presenterar strategiska fokusområden för 2022-2026 på kapitalmarknadsdagen

23 Aug, 2021

XVIVO Capital Markets Day 2021

13 Jul, 2021

XVIVO presents interim report January-June 2021

8 Jul, 2021

XVIVO to start their digital transformation journey together with UMC Groningen to enable an increase in successful transplants

30 Jun, 2021

Change in number of shares and votes in XVIVO Perfusion

28 Jun, 2021

Conference call on Interim Report

28 May, 2021

The National Institute for Health and Care Excellence (NICE) Gives Support for EVLP

25 May, 2021

Great interest for XVIVO’s European heart study

4 May, 2021

XVIVO submits 510(k) file with US FDA for Kidney Assist Transport

22 Apr, 2021

Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)

21 Apr, 2021

Interim report January-March 2021

19 Apr, 2021

Australian heart preservation study underway

8 Apr, 2021

Conference call on Interim Report

29 Mar, 2021

Annual report 2020

15 Mar, 2021

Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ)

26 Feb, 2021

Publication in The New England Journal of Medicine shows complications after liver transplantation significantly reduced with cold, oxygenated machine perfusion.